Céline Merlin

415 total citations
10 papers, 181 citations indexed

About

Céline Merlin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Céline Merlin has authored 10 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Céline Merlin's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA Interference and Gene Delivery (2 papers). Céline Merlin is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA Interference and Gene Delivery (2 papers). Céline Merlin collaborates with scholars based in Belgium, Australia and Netherlands. Céline Merlin's co-authors include Evelien Smits, Jorrit De Waele, Filip Lardon, Christophe Hermans, Laurie Freire Boullosa, Christophe Deben, Jinthe Van Loenhout, Guido Vanham, Stefaan C. De Smedt and Joanna Rejman and has published in prestigious journals such as Neurobiology of Aging, Cells and Cancers.

In The Last Decade

Céline Merlin

9 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Merlin Belgium 7 94 35 34 34 33 10 181
Wade R. Gutierrez United States 8 132 1.4× 19 0.5× 18 0.5× 33 1.0× 35 1.1× 18 206
Hannah Webber United Kingdom 6 119 1.3× 49 1.4× 98 2.9× 65 1.9× 14 0.4× 10 242
Tamrin Chowdhury South Korea 7 42 0.4× 18 0.5× 8 0.2× 20 0.6× 20 0.6× 14 123
Javal Sheth Canada 6 71 0.8× 28 0.8× 25 0.7× 13 0.4× 21 0.6× 10 170
Seulhee Kim United States 10 183 1.9× 37 1.1× 13 0.4× 95 2.8× 10 0.3× 18 294
Gürkan Mollaoglu United States 5 92 1.0× 63 1.8× 12 0.4× 101 3.0× 17 0.5× 5 222
Dennis S. Metselaar Netherlands 8 88 0.9× 24 0.7× 25 0.7× 19 0.6× 10 0.3× 13 148
Maria Lane United States 5 42 0.4× 11 0.3× 29 0.9× 64 1.9× 13 0.4× 8 108
Jaewan Jeon South Korea 11 139 1.5× 28 0.8× 7 0.2× 39 1.1× 40 1.2× 15 284
Ruben I. Calderon United States 5 83 0.9× 14 0.4× 11 0.3× 70 2.1× 15 0.5× 5 151

Countries citing papers authored by Céline Merlin

Since Specialization
Citations

This map shows the geographic impact of Céline Merlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Merlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Merlin more than expected).

Fields of papers citing papers by Céline Merlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Merlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Merlin. The network helps show where Céline Merlin may publish in the future.

Co-authorship network of co-authors of Céline Merlin

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Merlin. A scholar is included among the top collaborators of Céline Merlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Merlin. Céline Merlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.
2.
Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2023). Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants. 12(3). 667–667. 16 indexed citations
3.
Pauw, Ines De, Christophe Hermans, Hilde Lambrechts, et al.. (2023). Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. Cancer Drug Resistance. 6(4). 709–28. 2 indexed citations
4.
Flieswasser, Tal, Laurie Freire Boullosa, Christophe Hermans, et al.. (2023). Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer. OncoImmunology. 12(1). 2192100–2192100. 6 indexed citations
5.
Boullosa, Laurie Freire, Jinthe Van Loenhout, Christophe Hermans, et al.. (2022). Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics. 14(12). 2761–2761. 7 indexed citations
6.
Marcq, Elly, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2021). The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers. 13(2). 282–282. 23 indexed citations
7.
Loenhout, Jinthe Van, Laurie Freire Boullosa, Delphine Quatannens, et al.. (2021). Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma. Cells. 10(11). 2936–2936. 56 indexed citations
8.
Dillen, Lubina, Tim Van Langenhove, Sebastiaan Engelborghs, et al.. (2013). Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiology of Aging. 34(6). 1711.e1–1711.e5. 31 indexed citations
9.
Haes, Winni De, et al.. (2012). Internalization of mRNA Lipoplexes by Dendritic Cells. Molecular Pharmaceutics. 9(10). 2942–2949. 25 indexed citations
10.
Haes, Winni De, Joanna Rejman, Charlotte Pollard, et al.. (2012). Lipoplexes Carrying mRNA Encoding Gag Protein Modulate Dendritic Cells to Stimulate HIV-Specific Immune Responses. Nanomedicine. 8(1). 77–87. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026